Advertisement

Ads Placeholder
Loading...

Implanet S.A.

ALIMP.PAEURONEXT
Healthcare
Medical - Devices
0.22
-0.00(-1.35%)
U.S. Market opens in 7h 36m

Implanet S.A. Fundamental Analysis

Implanet S.A. (ALIMP.PA) shows moderate financial fundamentals with a PE ratio of -8.28, profit margin of -35.13%, and ROE of 13.76%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.40

Areas of Concern

Operating Margin-43.71%
Cash Position1.38%
Current Ratio0.72
We analyze ALIMP.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 69.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
69.8/100

We analyze ALIMP.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

ALIMP.PA struggles to generate sufficient returns from assets.

ROA > 10%
-26.50%

Valuation Score

Excellent

ALIMP.PA trades at attractive valuation levels.

PE < 25
-8.28
PEG Ratio < 2
-0.40

Growth Score

Weak

ALIMP.PA faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

ALIMP.PA shows balanced financial health with some risks.

Debt/Equity < 1
-4.49
Current Ratio > 1
0.72

Profitability Score

Weak

ALIMP.PA struggles to sustain strong margins.

ROE > 15%
13.76%
Net Margin ≥ 15%
-35.13%
Positive Free Cash Flow
No

Key Financial Metrics

Is ALIMP.PA Expensive or Cheap?

P/E Ratio

ALIMP.PA trades at -8.28 times earnings. This suggests potential undervaluation.

-8.28

PEG Ratio

When adjusting for growth, ALIMP.PA's PEG of -0.40 indicates potential undervaluation.

-0.40

Price to Book

The market values Implanet S.A. at -26.59 times its book value. This may indicate undervaluation.

-26.59

EV/EBITDA

Enterprise value stands at -5.69 times EBITDA. This is generally considered low.

-5.69

How Well Does ALIMP.PA Make Money?

Net Profit Margin

For every $100 in sales, Implanet S.A. keeps $-35.13 as profit after all expenses.

-35.13%

Operating Margin

Core operations generate -43.71 in profit for every $100 in revenue, before interest and taxes.

-43.71%

ROE

Management delivers $13.76 in profit for every $100 of shareholder equity.

13.76%

ROA

Implanet S.A. generates $-26.50 in profit for every $100 in assets, demonstrating efficient asset deployment.

-26.50%

Following the Money - Real Cash Generation

Operating Cash Flow

Implanet S.A. generates limited operating cash flow of $-242.33K, signaling weaker underlying cash strength.

$-242.33K

Free Cash Flow

Implanet S.A. generates weak or negative free cash flow of $-1.07M, restricting financial flexibility.

$-1.07M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

ALIMP.PA converts -3.90% of its market value into free cash.

-3.90%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.28

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.40

vs 25 benchmark

P/B Ratio

Price to book value ratio

-26.59

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.52

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-4.49

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.72

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

13.76

vs 25 benchmark

ROA

Return on assets percentage

-0.27

vs 25 benchmark

ROCE

Return on capital employed

-86.54

vs 25 benchmark

How ALIMP.PA Stacks Against Its Sector Peers

MetricALIMP.PA ValueSector AveragePerformance
P/E Ratio-8.2828.54 Better (Cheaper)
ROE1375.82%738.00% Excellent
Net Margin-35.13%-43982.00% (disorted) Weak
Debt/Equity-4.490.34 Strong (Low Leverage)
Current Ratio0.722806.01 Weak Liquidity
ROA-26.50%-14624.00% (disorted) Weak

ALIMP.PA outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Implanet S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ